Widespread countervailing genomic responses induced by chemotherapy or radiation as a cause of therapeutic failure

Medical Hypotheses

Volumn 54, Issue 6, 2000, Pages 1000-1002

  Anderson, K M ^a   Alrefai, W A ^a   Anderson, C A ^b   Bonomi, P ^a   Harris, J E ^a  

^a RUSH MEDICAL COLLEGE   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CELL; CANCER CHEMOTHERAPY; CELL KILLING; GENOME; PRIORITY JOURNAL; RADIOTHERAPY; SHORT SURVEY; TREATMENT FAILURE;

EID: 0033936605     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.1999.1016     Document Type: Article

References (19)

1. Hait W. N. Drug Resistance. 1996;1-408 Kluwer Academic Publishers, Boston.
2. Pinelo H. M., Giacone G. Drug Resistance in the Treatment of Cancer. 1998;1-314 Cambridge U Press, Cambridge, UK
3. Foster P. L. Genomic adaptation: the uses of adversity. Ann Rev Micro. 47:1993;467-504.
4. Dole M., Nunez G., Merchant A. K., Maybaum J., Rode C. K., Bloch C. A., Castle V. P. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Can Res. 54:1992;3253-3259.
5. Anderson K. M., Seed T., Meng J., Ou D., Alrefai W. A., Harris J. E. Five lipoxygenase inhibitors reduce Panc-1 survival: The mode of cell death and synergism with gamma linolenic acid. Antican Res. 18:1998;791-800.
6. Atlas Human cDNA Expression Array Manual. Clontech, Palo Alto, CA.
7. Anderson K. M., Alfreai W. A., Anderson C. A., Bonomi P., Dudeja P., Ou D., Harris J. E. Altered oncogene, tumor suppressor and cell-cycle gene expression in Pane-1 cells cultured with the pleiotropic 5-lipoxygenase inhibitor, MK 886, assessed with a gene chip. Antican Res. 1999.
8. Walden, T. L. Farzaneh, N. K. Biochemistry of Ionizing Radiation. Raven Press, NY, 1990, 1, 243.
9. Rowley R., Phillips E. N., Schroeder A. L. The effect of ionizing radiation on DNA synthesis in eukaryotic cells. Int J Rad Biol. 75:1998;267-286.
10. Taylor E. M., Lehmann A. R. Review: conservation of eukaryotic DNA repair mechanisms. Int J Rad Biol. 74:1998;277-286.
11. DeRisi J., Iyer V. R., Brawn P. O. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science. 278:1997;680-686.
12. Cho R. J., Campbell M. J., Winzeler E. A., Steinn L., Conway A., Wodicka L., Wolfsberg T. G., Gabrielian A. E., Landsman D., Lockhart D. J., Davis R. W. A genome-wide transcriptional analysis of the mitotic cell cycle. Molecular Cell. 2:1999;65-73.
13. Eisen M. B., Spellman P. T., Brown P. O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 95:1998;14863-14868.
14. Ermolaeva O., Rastogi M., Pruitt K. D., Schuler G. D., Bittner M. L., Chen Y., Simon R., Meltzer P., Trent J. M., Boguski M. S. Data management and analysis for gene expression arrays. Nature Gen. 20:1998;19-23.
15. Klevecz B. Field of Genes. Mathcad turns mictroassays into live images. The Scientist. 1999 March 29;24.
16. Kitada S., Takayama S., de Riel K., Tanaka S., Reed J. C. Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of Bcl 2 expression. Antisense Res Dev. 4:1994;71-79.
17. Miyashita T., Reed J. C. Bcl-2 gene transfer increases relative resistance of S49.1 and WEH17.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoid and multiple chemotherapeutic drugs. Can Res. 52:1992;5407-5411.
18. O'Rielly M. S., Holmgren L., Chen C., Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med. 2:1996;689-692.
19. Pandey S., Wang E. Cells en route to apoptosis are characterized by the up-regulation of c-fos, c-myc, c-jun, CDC2 and RB phosphorylation, resembling events of early cell-cycle transit. J Cell Biochem. 58:1995;135-150.